元征科技(02488.HK)以代價3億人幣出售西安附屬
元征科技(02488.HK)公布,計劃出售西安元征軟件科技全部股權,代價為3億元人民幣(下同),代價包括股權代價1.66億元及與貸款轉讓相關的股東貸款代價1.34億元。
西安元征軟件科技就該地塊擁有的物業權位於西安,總建築面積約4.86萬平方米。
公司指,鑒於位於該地塊上的物業仍在建造中及由於中國建築成本上漲,長遠而言,其將持續需要公司承諾作出更大額的進一步投資。鑒於該地塊於中短期內並不會產生任何收入或收益,董事會認為,出售事項為公司提供增強其流動資金的機會,並令公司免於作出上述持續性長期投資承諾。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.